Submitted:
20 October 2024
Posted:
21 October 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Material and Methods
2.1. Sample Collection and Evaluation of CTP Concentration
2.2. Subjects
2.3. Surgery
2.4. Pure Tone Audiometry
2.5. Vestibular Symptoms
2.6. Intraoperative findings
3. Results
3.1. Patient Characteristics
3.2. Surgery
3.3. Hearing Outcome after Surgery
3.4. Intraoperative Observation
3.5. CTP Results
3.6. Vertigo
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
References
- National Institute of Health. Sudden deafness (NIH publication 00-4757). Bethesda (MD): National Institutes of Health; 2000.
- Koc A, Sanisoglu O. Sudden sensorineural hearing loss: Literature review on recent studies. J Otolaryngol. 2003;32:308–13.
- Schreiber BE, Agrup C, Haskard DO, Luxon LM. Sudden sensorineural hearing loss. Lancet. 2010 Apr 3;375(9721):1203-11. [CrossRef] [PubMed]
- Clinical Practice Guideline: Sudden Hearing Loss (Update).Otolaryngology–Head and Neck Surgery 2019, Vol. 161(1S) S1–S45.
- Bussieres R, Portmann D, Noyon P. When to suspect a perilymphatic fistula. Rev Laryngol Otol Rhinol (Bord) 2003;124(4):259-64.
- Arndt HJ. Spontaneous perforation of the membrane of the round window—a major cause of sudden deafness. Laryngol Rhinol Otol (Stuttg) 1984;63(9):439-44.
- Maier W, Fradis M, Kimpel S et al. Results of exploratory tympanotomy following sudden unilateral deafness and its effect on hearing restoration.Ear Nose Throat J 2008;87:438-51.
- Arenberg IK,Wu CM. Fluorescein as an easy, low-cost, ind irect, or reverse intraoperative marker to rule out perilymph versus localinjection. Am J OtoI19 96;17(2):259-62.
- LevensonMJ,DeslogeRB,ParisierSc. Beta-2 transferrin:Limitations of use as a clinical marker for perilymph. Laryngoscope 1996;106(2 Pt 1):159-61.
- Arenberg IK,Wu CM. Fluorescein as an easy, low-cost, ind irect, or reverse intraoperative marker to rule out perilymph versus local injection.Am J OtoI19 96;17(2):259-62.
- Bachmann-Harildstad G, Stenklev NC, Myrvoll E, Jablonski G, Klingenberg O. β-trace protein as a diagnostic marker for perilymphatic fluid fistula: a prospective controlled pilot study to test a sample collection technique. Otol Neurotol. 2011;32(1):7-10. [CrossRef]
- Ikezono T, Matsumura T, Matsuda H, Shikaze S, Saitoh S, Shindo S, et al. The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage. PLoS One. (2018) 13:e0191498. [CrossRef]
- Todt I,, Eduardo Martin Sainz, Ikezono T. Perilymphatic fistula, The New Era, CP0005 Journal of Vestibular research, vol. 32, no. s1, pp. SI-S327, 2022, XXXI Bárány Society Meeting, May 9th to May 11th, 2022, Madrid, Spain.
- Sasaki A, Ikezono T, Matsuda H, Araki R, Matsumura T, Saitoh S, Wasano K, Matsubara A. Prevalence of perilymphatic fistula in patients with sudden-onset sensorineural hearing loss as diagnosed by Cochlin-tomoprotein (CTP) biomarker detection: its association with age, hearing severity, and treatment outcomes. Eur Arch Otorhinolaryngol. 2024 May;281(5):2373-2381. Epub 2023 Dec 21. [CrossRef] [PubMed]
- Haile LM, Orji AU, Reavis KM, Briant PS, Lucas KM, Alahdab F, Bärnighausen TW, Bell AW, Cao C, Dai X, Hay SI, Heidari G, Karaye IM, Miller TR, Mokdad AH, Mostafavi E, Natto ZS, Pawar S, Rana J, Seylani A, Singh JA, Wei J, Yang L, Ong KL, Steinmetz JD; GBD 2019 USA Hearing Loss Collaborators. Hearing Loss Prevalence, Years Lived With Disability, and Hearing Aid Use in the United States From 1990 to 2019: Findings From the Global Burden of Disease Study. Ear Hear. 2024 Jan-Feb 01;45(1):257-267. Epub 2023 Sep 15. [CrossRef] [PubMed]
- Prenzler NK, Schwab B, Kaplan DM, El-Saied S. The role of explorative tympanotomy in patients with sudden sensorineural hearing loss with and without perilymphatic fistula. Am J Otolaryngol. 2018 Jan-Feb;39(1):46-49. doi: 10.1016/j.amjoto.2017.10.006. Epub 2017 Oct 9. Epub 2017 Oct 9. [CrossRef]
- Ryosuke Kitoh, Shin-ya Nishio, Kaoru Ogawa, Sho Kanzaki, Naohito Hato, Michihiko Sone, Satoshi Fukuda, Akira Hara, Tetsuo Ikezono, Kotaro Ishikawa, Satoshi Iwasaki, Kimitaka Kaga, Seiji Kakehata, Atsushi Matsubara, Tatsuo Matsunaga, Takaaki Murata, Yasushi Naito, Takashi Nakagawa, Kazunori Nishizaki, Yoshihiro Noguchi, Hajime Sano, Hiroaki Sato, Mikio Suzuki, Hideo Shojaku, Haruo Takahashi, Hidehiko Takeda, Testuya Tono, Hiroshi Yamashita, Tatsuya Yamasoba & Shin-ichi Usami (2017): Nationwide epidemiological survey of idiopathic sudden sensorineural hearing loss in Japan, Acta Oto-Laryngologica. [CrossRef]
- Heiden C, Porzsolt F, Biesinger E, Höing R. Die Spontanheilung des Hörsturzes [Spontaneous remission of sudden deafness]. HNO. 2000 Aug;48(8):621-3. German. [CrossRef] [PubMed]
- Matsuda H, Sakamoto K, Matsumura T, Saito S, Shindo S, Fukushima K, et al. A nationwide multicenter study of the Cochlin Tomo-protein detection test: clinical characteristics of perilymphatic fistula cases. Acta Otolaryngol. (2017) 137:S53–9. [CrossRef]
- Weinaug P: Spontaneous remission in sudden deafness. HNO 1984;32(8):346-351.
- Hornibrook J. Perilymph fistula: fifty years of controversy. ISRN Otolaryngol. 2012 Jul 31;2012:281248. [CrossRef] [PubMed]
- Freeman P (1975) Rupture of the round window membrane. Acta Otolaryngol (Belg) 29(5):783–794.
- Simmons F. The double-membrane break syndrome in sudden hearing loss. Laryngoscope 1979;89:59-66.





![]() |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
